Lexicon Pharmaceuticals
LXRX
#7257
Rank
โ‚น45.48 B
Marketcap
โ‚น108.85
Share price
-2.44%
Change (1 day)
65.84%
Change (1 year)

Market capitalization of Lexicon Pharmaceuticals (LXRX)

Market cap: โ‚น45.48 Billion

As of February 2026 Lexicon Pharmaceuticals has a market cap of โ‚น45.48 Billion. This makes Lexicon Pharmaceuticals the world's 7257th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lexicon Pharmaceuticals from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น45.48 B13.36%
2025โ‚น40.12 B67.3%
2024โ‚น23.98 B-23.12%
2023โ‚น31.19 B4.59%
2022โ‚น29.82 B-31.69%
2021โ‚น43.66 B23.38%
2020โ‚น35.39 B12.53%
2019โ‚น31.45 B-36.05%
2018โ‚น49.17 B-26.17%
2017โ‚น66.60 B-31.87%
2016โ‚น97.77 B6.68%
2015โ‚น91.65 B119.42%
2014โ‚น41.77 B-26.81%
2013โ‚น57.07 B-7.94%
2012โ‚น61.99 B169.05%
2011โ‚น23.04 B5.84%
2010โ‚น21.77 B57.09%
2009โ‚น13.85 B50.56%
2008โ‚น9.20 B-43.41%
2007โ‚น16.26 B30.76%
2006โ‚น12.43 B17.32%
2005โ‚น10.60 B-50.28%
2004โ‚น21.32 B26.56%
2003โ‚น16.84 B41.84%
2002โ‚น11.87 B-58.99%
2001โ‚น28.96 B-22.66%
2000โ‚น37.45 B

End of Day market cap according to different sources

On Feb 9th, 2026 the market cap of Lexicon Pharmaceuticals was reported to be:

โ‚น46.48 Billion
by Nasdaq info icon info icon
โ‚น45.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น18.633 T 40,866.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น1.634 T 3,493.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.482 T 16,350.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น208.98 B 359.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น333.72 B 633.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น71.99 B 58.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น68.35 B 50.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.007 T 2,114.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.21 B-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA